Retreatment with fludarabine and cyclosporine for one case of refractory pure red cell aplasia.
He
Guang-sheng
GS
Department of Clinical Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Insititute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou 215006. heguangsheng30@yahoo.com.cn
Zhang
Xiang
X
Wu
De-pei
DP
Sun
Ai-ning
AN
Miao
Miao
M
Wang
Xiu-li
XL
Jin
Zheng-ming
ZM
D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy*; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D014740:Vidarabine; C024352:fludarabine